Despite the overwhelming prevalence of TDP-43 pathology in ALS/FTD and related diseases, mutations in the gene encoding TDP-43 (TARDBP) are only present in less than 1% of all ALS and FTD cases [21]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.